Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy AFT Pharmaceuticals shares (AFT)

Your easy-to-follow guide to buying AFT Pharmaceuticals shares on the NZX.

AFT Pharmaceuticals logo

AFT Pharmaceuticals is a multinational pharmaceutical company based in New Zealand. Shares in the company are listed on the NZX — if you’d like to buy AFT shares, keep reading for step-by-step instructions on what you need to do.

About our promoted products: Our ‘promoted’ products are presented as a result of a commercial advertising arrangement or to highlight a particular feature. Promoted products are not a recommendation, an indication a product is the best in its category, nor represent all products in the market. It is important to compare your options and find the right product for you.
Some of our promoted products are CFD providers. CFDs are complex financial products and traders are at high risk of losing all of or more than their initial investment

How to buy shares in AFT Pharmaceuticals on the New Zealand Exchange

  1. Compare share trading platforms. If you’re a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table. Most importantly, you need to find a share trading platform that allows you to trade on the NZX.
  2. Open and fund your share trading account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for AFT Pharmaceuticals. Find the stock by name or ticker symbol: AFT. Research its history to confirm it’s a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until AFT Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimise risk through the market’s ups and downs. You may be able to buy a fractional share of AFT Pharmaceuticals, depending on your share trading account.
  6. Check in on your investment. Congratulations, you own a part of AFT Pharmaceuticals. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Compare NZX share trading platforms

Name Product Available Investment Types Min. Monthly Fee Available Markets
Sharesies
Shares, ETFs, Managed Funds, Index Funds
$0
US, NZ, AU, Funds with exposure to multiple markets
Trade and invest in more than 5,000 companies, ETFs and managed funds across New Zealand, the US and Australia.
ASB Securities
Shares, ETFs, Bonds
$0
NZ, AU, Funds with exposure to multiple markets
Direct Broking
Shares, ETFs, Bonds
$5 per month
NZ, AU, Funds with exposure to multiple markets
loading

Compare up to 4 providers

AFT Pharmaceuticals overview and background

Founded in 1998, AFT Pharmaceuticals researches and develops a wide range of pharmaceutical products. With a company vision to “develop innovative products that help people”, AFT Pharmaceuticals’ range includes products for everything from pain management and skin care to digestive health and eye care.

Headquartered in Auckland, AFT Pharmaceuticals also has offices in Australia and Malaysia. It offers over 130 prescription and non-prescription products throughout Australasia, plus it also exports or licenses its products to over 100 countries around the world.

Performance and company results

In its FY21 annual report, AFT Pharmaceuticals announced the following results for the year ended 31 March 2021:

  • Total revenue of $113.1 million (an increase of 7%)
  • Operating profit of $10.8 million (a drop of 5% on an underlying basis)
  • Profit after tax on an underlying basis of $7.8 million (up from $2.9 million in the prior year)
  • Total assets of $104.7 million (an increase of 20.2%)

Key details

NameAFT Pharmaceuticals LimitedIndustryDrug Manufacturing, Distribution & Research
Ticker symbolAFTISINNZAFTE0001S4
TypeOrdinary SharesDate listed on NZX22 Dec 2015
End of financial yearMarchChief executive officerHartley Atkinson
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site